Document is current

Article History

Received: 4 September 2024

Accepted: 13 November 2024

First Online: 27 January 2025

Declarations

:

: Ethics approval and consent to participate are not applicable to this review article.

: Not applicable.

: Dr. Persia Pourshahnazari has received consulting fees and honoraria from Takeda, CSL Behring, Grifols, Octapharma, AstraZeneca, Novartis, Sanofi, Valeo Pharma, Bausch Healthcare, ALK, and Stallergenes Greer. Dr. Stephen D. Betschel has received consulting fees, honoraria, and research funding from Astria, Canadian Blood Services, CSL Behring, Green Cross, Grifols, Ionis Pharmaceuticals, Kalvista Novartis, Octapharma, Pharvaris, Sanofi, Takeda, and WSIB. Dr. Vy H.D. Kim is a medical advisory board member of Immunity Canada and is a clinical trial investigator for ALK-Abello and DBV Technologies. Dr. Susan Waserman has received consulting fees and honoraria from AstraZeneca, GlaxoSmithKline, Novartis, ALK, Bausch Health, Mylan, Meda, CSL Behring, Sanofi, Takeda, Pfizer, Sanofi, Medexus Pharma, and Miravo. She is a clinical trial investigator for Aimmune. She is the President of the Canadian Allergy, Asthma and Immunology Foundation (CAAIF), and medical advisor to Food Allergy Canada. Dr. Rongbo Zhu has received consulting fees/honoraria from ALK, AstraZeneca, Bausch Health, GlaxoSmithKline, Medexus Pharmaceuticals, Sanofi, Stallergenes Greer, ValeoPharma. Dr. Harold Kim has received honoraria and/or consulting fees from ALK, AstraZeneca, Bausch Health, CSL Behring, GSK, Miravo, Novartis, Medexus, Pfizer, Sanofi, Shire, Takeda.